Post-doctoral research fellow
|
Sangnam Kim, Ph.D. (skim52@nd.edu)
|
Biography/ Research Summary
Dr. Kim received her Ph.D. in Public Health from Keimyung University in South Korea. She has been worked as a postdoctoral research fellow in the Laboratory of Molecular Pharmacology and Toxicology under at Yonsei University and Seoul National University. Before coming to Notre Dame, Kim Ph.D was worked at the Keck School of Medicine Cancer Center at University of Southern California. Her research interests are in the area of molecular biology of obesity of mechanism and cancer. In September 2020, she joined in the Yoon’s Lab as a postdoctoral research associate. The principal duties and responsibilities of the appointment are to develop Cas9-ribonucleaoprein (RNP) to ablate PD-1 of T cells for in vitro and in vivo mouse experiments.
Dr. Kim received her Ph.D. in Public Health from Keimyung University in South Korea. She has been worked as a postdoctoral research fellow in the Laboratory of Molecular Pharmacology and Toxicology under at Yonsei University and Seoul National University. Before coming to Notre Dame, Kim Ph.D was worked at the Keck School of Medicine Cancer Center at University of Southern California. Her research interests are in the area of molecular biology of obesity of mechanism and cancer. In September 2020, she joined in the Yoon’s Lab as a postdoctoral research associate. The principal duties and responsibilities of the appointment are to develop Cas9-ribonucleaoprein (RNP) to ablate PD-1 of T cells for in vitro and in vivo mouse experiments.